Abstract
Enterobacteriaceae and non fermenting Gram-negative bacilli have become a threat to public health, in part due to their resistance to multiple antibiotic classes, which ultimately have led to an increase in morbidity and mortality. β-lactams are currently the mainstay for combating infections caused by these microorganisms, and β-lactamases are the major mechanism of resistance to this class of antibiotics. Within the β-lactamases, carbapenemases pose one of the gravest threats, as they compromise one of our most potent lines of defense, the carbapenems. Carbapenemases are being continuously identified worldwide; and in Latin America, numerous members of these enzymes have been reported. In this region, the high incidence of reports implies that carbapenemases have become a menace and that they are an issue that must be carefully studied and analyzed.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acinetobacter baumannii / drug effects
-
Acinetobacter baumannii / enzymology
-
Acinetobacter baumannii / isolation & purification
-
Bacterial Proteins / classification
-
Bacterial Proteins / genetics
-
Bacterial Proteins / physiology*
-
Carbapenems / therapeutic use*
-
Drug Resistance, Bacterial
-
Enterobacteriaceae / drug effects
-
Enterobacteriaceae / enzymology*
-
Enterobacteriaceae / isolation & purification
-
Enterobacteriaceae Infections / drug therapy*
-
Geography
-
Gram-Negative Bacteria / drug effects
-
Gram-Negative Bacteria / enzymology
-
Humans
-
Klebsiella pneumoniae / drug effects
-
Klebsiella pneumoniae / enzymology
-
Klebsiella pneumoniae / isolation & purification
-
Latin America
-
Pseudomonas aeruginosa / drug effects
-
Pseudomonas aeruginosa / enzymology
-
Pseudomonas aeruginosa / isolation & purification
-
beta-Lactamases / classification
-
beta-Lactamases / genetics
-
beta-Lactamases / physiology*
Substances
-
Bacterial Proteins
-
Carbapenems
-
beta-Lactamases
-
carbapenemase